Influence of Educational Stimuli From the Pé-de-Meia Program on Delay Discounting Propensity
Launched by FEDERAL INSTITUTE OF EDUCATION, SCIENCE AND TECHNOLOGY OF THE STATE OF MATO GROSSO · Mar 27, 2024
Trial Information
Current as of July 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a program called Pé-de-Meia, which offers financial and educational incentives, can change the way low-income high school students make decisions about their future. Specifically, the study is looking at something called "delay discounting," which is when people prefer getting a smaller reward now instead of waiting for a bigger reward later. The researchers want to see if the program's educational messages can help students think differently about immediate versus future rewards, and how this affects their choices regarding schooling and using the program’s benefits.
To participate in the study, students must be low-income high schoolers enrolled in public schools and registered in a specific government program called CadÚnico. They will take part in a computerized game that mimics real-life decision-making and fill out questionnaires about their preferences and backgrounds. The trial will compare how different groups of students respond to various educational messages to see if these incentives help them stay in school and succeed academically. This research aims to improve educational policies for low-income adolescents and support their academic journeys.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Low-income high school students in the public system, registered in CadÚnico
- Exclusion Criteria:
- • Students with a formal psychological or psychiatric diagnosis
About Federal Institute Of Education, Science And Technology Of The State Of Mato Grosso
The Federal Institute of Education, Science and Technology of the State of Mato Grosso (IFMT) is a prominent educational and research institution dedicated to advancing knowledge and innovation in the fields of education and technology. Committed to fostering scientific research and development, IFMT actively engages in clinical trials aimed at improving public health outcomes and enhancing community well-being. With a focus on collaboration and ethical standards, the institute leverages its academic expertise and resources to contribute to the advancement of medical science, ensuring rigorous methodologies and impactful findings that benefit both local and broader populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported